在病人身上进行首次试验是非常重要和让人非常激动的，这是在用基因治疗手段治疗多种眼科疾病上的巨大的一步。
Testing it for the first time in patients is very important and exciting, and represents a huge step towards establishing gene therapy for the treatment of many different eye conditions.
胞内抗体作为一种新的基因治疗工具，在肿瘤基因治疗、人艾滋病基因治疗的实验研究及潜在的临床治疗方面展示了广泛的应用前景。
As a new gene therapy tool, intrabody brings forth extensive application foreground in the aspects of tumor gene therapy and human HIV gene therapy's experimental study and potential clinical therapy.
目的：构建含人IL -21基因的重组腺病毒表达载体，为IL - 21基因治疗肿瘤研究奠定基础。
Objective: to be as the foundation of the tumor therapy with targeting IL-21 gene by constructing of recombinant interleukin 21 gene adenovirus expression vector.
超过30人经治疗后已在三个LCA的基因治疗试验，在2007年和2008年开始的。
More than 30 people have been treated in three LCA gene therapy trials that began in 2007 and 2008.
目的研究转人IL2基因对原代肾细胞癌(RCC)细胞致瘤性的影响，为RCC的基因治疗提供依据。
Objective to study the influence on tumorigenicity of human renal cell carcinoma (RCC) cells transduced with human IL 2 gene, and to intend in forming a basis for RCC gene therapy.
目的研究转人IL2基因对原代肾细胞癌(RCC)细胞致瘤性的影响，为RCC的基因治疗提供依据。
Objective to study the influence on tumorigenicity of human renal cell carcinoma (RCC) cells transduced with human IL 2 gene, and to intend in forming a basis for RCC gene therapy.
应用推荐